2/4/25 17:54 | 2/3/25 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S.d | -303 | 2.10 | 0 | -144 | -5 | 2,924 | D | | | | | | | | | | | | | | |
3/1/24 17:47 | 2/29/24 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S | -74 | 1.58 | 0 | -47 | -2 | 2,364 | D | | | | | | | | | | | | | | |
2/29/24 18:00 | 2/27/24 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S | -57 | 1.52 | 0 | -38 | -2 | 2,411 | D | | | | | | | | | | | | | | |
2/2/24 16:10 | 2/1/24 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S.d | -78 | 1.68 | 0 | -46 | -2 | 2,449 | D | | | | | | | | | | | | | | |
6/15/23 16:28 | 6/14/23 | ZYNE | Zynerba Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | PA | D | | S.d | 0 | 0.3481 | 0 | 0 | 0 | 81 | D | | | | | | | | | | | | | | |
3/3/23 08:01 | 3/1/23 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S | -81 | 0.8775 | 0 | -92 | -5 | 1,889 | D | | | | | | | | | | | | | | |
3/1/23 16:07 | 2/27/23 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S | -31 | 0.8132 | 0 | -39 | -2 | 1,981 | D | | | | | | | | | | | | | | |
6/16/22 21:48 | 6/14/22 | ZYNE | Zynerba Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | PA | D | | S.d | 0 | 1.01 | 0 | 0 | 0 | 33 | D | | | | | | | | | | | | | | |
3/2/22 21:25 | 2/28/22 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S.dm | -171 | 2.17 | 0 | -79 | -4 | 1,723 | D | | | | | | | | | | | | | | |
4/1/21 20:32 | 4/1/21 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S | -14 | 3.40 | 0 | -4 | 0 | 1,534 | D | | | | | | | | | | | | | | |
3/2/21 16:10 | 3/1/21 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S.d | -170 | 3.40 | 0 | -50 | -3 | 1,499 | D | | | | | | | | | | | | | | |
11/21/19 06:32 | 11/20/19 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | P | 172 | 3.44 | 0 | 50 | 5 | 1,070 | D | | | | | | | | | | | | | | |
6/5/19 16:05 | 6/3/19 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | M.d | 135 | 0.4700 | 0 | 287 | 39 | 1,018 | D | | | | | | | | | | | | | | |
8/22/18 16:39 | 8/22/18 | ZYNE | Zynerba Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | PA | D | | P | 32 | 6.43 | 0 | 5 | New | 5 | D | | | | | | | | | | | | | | |
7/12/18 16:59 | 7/11/18 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | M.d | 47 | 0.4700 | 0 | 100 | 24 | 510 | D | | | | | | | | | | | | | | |
1/23/17 16:10 | 1/19/17 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | M.d | 9 | 0.4700 | 3 | 20 | 6 | 373 | D | -8 | 27 | 11 | 19 | 14 | -8 | -9 | -2 | 2 | 6 | 9 | -2 | | |
6/8/16 17:19 | 6/7/16 | RLYP | Relypsa Inc | | Health | Drug | Pharmaceutical Preparations | Butler John P. | CA | D | | S | -20 | 19.32 | 33 | -1 | -26 | 3 | D | -21 | -46 | -34 | 43 | 5 | 32 | 17 | -7 | -2 | 1 | 2 | | | |
1/19/16 16:00 | 1/15/16 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | M.d | 12 | 0.4700 | 8 | 25 | 12 | 226 | D | | -23 | -28 | -27 | -21 | -36 | -19 | -6 | 3 | 1 | 6 | 25 | 9 | 25 |
6/15/15 18:40 | 6/11/15 | RLYP | Relypsa Inc | | Health | Drug | Pharmaceutical Preparations | Butler John P. | CA | D | | S | -38 | 34.62 | 13 | -1 | -22 | 4 | D | | 44 | 7 | -16 | 12 | -1 | -4 | -3 | 0 | -1 | -6 | -28 | -18 | -43 |
5/28/15 06:31 | 5/26/15 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | M.d | 24 | 0.4700 | 3 | 50 | 34 | 198 | D | | -64 | -42 | -14 | -11 | 9 | 1 | 1 | 0 | -3 | 14 | -26 | 14 | 8 |
3/11/15 06:23 | 3/9/15 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | M.d | 47 | 0.4700 | 1 | 100 | 207 | 148 | D | | | -49 | 9 | 0 | 13 | 23 | 4 | 0 | 12 | -10 | -31 | -32 | -27 |
12/29/14 17:16 | 12/29/14 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | P | 12 | 11.57 | 2 | 1 | 2 | 48 | D | | | -60 | -50 | 2 | 10 | 4 | -6 | 2 | -2 | -5 | -4 | -17 | 5 |
12/22/14 16:11 | 12/22/14 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | P | 12 | 11.92 | 2 | 1 | 2 | 47 | D | | | -59 | -43 | 11 | 3 | 4 | 8 | -6 | -7 | -15 | -6 | -21 | 0 |
12/18/14 16:02 | 12/15/14 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | P | 11 | 11.34 | 2 | 1 | 2 | 46 | D | | | -56 | -47 | 11 | -10 | 3 | 5 | -1 | -6 | -9 | 4 | -34 | -3 |
11/13/14 06:21 | 11/11/14 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | M.d | 14 | 0.4700 | 5 | 31 | 205 | 45 | D | | | -43 | -49 | -41 | -37 | 0 | 14 | -7 | 25 | -7 | -24 | -33 | -30 |
11/13/14 06:21 | 11/12/14 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | P.d | 10 | 10.31 | 5 | 1 | 2 | 45 | D | | | -43 | -49 | -41 | -37 | 0 | 14 | -7 | 25 | -7 | -24 | -33 | -30 |
3/27/14 16:00 | 3/25/14 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | P,CEO | P | 235 | 17.00 | 30 | 14 | New | 14 | D | | | | | | | | -20 | 3 | 13 | 19 | 49 | 8 | -48 |